Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Keratosis, Actinic 34Brain Neoplasms 21Glioblastoma 20Glioma 18Carcinoma, Basal Cell 9Skin Neoplasms 5Precancerous Conditions 5Astrocytoma 5Gliosarcoma 4Oligodendroglioma 3Neoplasms 3Mouth Neoplasms 3Carcinoma, Squamous Cell 3Squamous Intraepithelial Lesions 2Skull Base Neoplasms 2Skin Diseases 2Sarcoma 2Pituitary Neoplasms 2Mycosis Fungoides 2Meningioma 2Lymphoma, T-Cell, Cutaneous 2Leukoplakia, Oral 2Head and Neck Neoplasms 2Central Nervous System Neoplasms 2Basal Cell Nevus Syndrome 2Urinary Bladder Neoplasms 1The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Ovarian Neoplasms 1

Interventions

mirdametinib 3Imatinib Mesylate 3Surveys and Questionnaires 2tipifarnib 1talimogene laherparepvec 1pirfenidone 1nilotinib 1emvododstat 1diphenylcyclopropenone 1cabozantinib 1binimetinib 1Sunitinib 1Sirolimus 1Sevoflurane 1Propofol 1Percutaneous Collagen Induction 1Nitrous Oxide 1Magnetic Resonance Spectroscopy 1Lidocaine 1Lasers, Solid-State 1Lasers 1Glycopyrrolate 1Dexmedetomidine 1Blood Specimen Collection 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatoses × Aminolevulinic Acid × Clear all
NCT01682811 2021-06-18

Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)

Medical College of Wisconsin

Phase 1 Completed
20 enrolled 11 charts
CNS

Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡